51. 全身性強皮症 Scleroderma Clinical trials / Disease details


臨床試験数 : 525 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05559580
(ClinicalTrials.gov)
November 24, 202226/9/2022A Study in People With Systemic Sclerosis to Test Whether BI 685509 Has an Effect on Lung Function and Other Systemic Sclerosis SymptomsA Phase II, Randomised, Placebo-controlled, Double-blind, Parallel Group, Efficacy and Safety Study of at Least 48 Weeks of Oral BI 685509 Treatment in Adults With Early Progressive Diffuse Cutaneous Systemic SclerosisScleroderma, SystemicDrug: BI 685509;Drug: PlaceboBoehringer IngelheimNULLRecruiting18 YearsN/AAll200Phase 2Australia;Austria;Belgium;Canada;China;Czechia;Finland;France;Greece;Italy;Japan;Korea, Republic of;Malaysia;Netherlands;New Zealand;Poland;Romania;Singapore;Spain;Sweden;Thailand